Ameritas Investment Partners Inc. increased its position in shares of Colgate-Palmolive Company (NYSE:CL) by 0.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 23,557 shares of the company’s stock after buying an additional 96 shares during the period. Ameritas Investment Partners Inc.’s holdings in Colgate-Palmolive were worth $1,723,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. AlphaMark Advisors LLC increased its stake in Colgate-Palmolive by 452.1% in the first quarter. AlphaMark Advisors LLC now owns 1,673 shares of the company’s stock valued at $122,000 after buying an additional 1,370 shares in the last quarter. Security Asset Management purchased a new stake in shares of Colgate-Palmolive during the fourth quarter worth $131,000. North Star Investment Management Corp. boosted its stake in shares of Colgate-Palmolive by 3.9% in the first quarter. North Star Investment Management Corp. now owns 1,797 shares of the company’s stock worth $132,000 after buying an additional 67 shares during the last quarter. Blue Chip Partners Inc. boosted its stake in shares of Colgate-Palmolive by 0.4% in the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock worth $132,000 after buying an additional 8 shares during the last quarter. Finally, Advantage Investment Management LLC boosted its stake in shares of Colgate-Palmolive by 16.8% in the first quarter. Advantage Investment Management LLC now owns 1,850 shares of the company’s stock worth $135,000 after buying an additional 266 shares during the last quarter. 73.69% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Colgate-Palmolive Company (NYSE CL) opened at 71.02 on Friday. The company has a market cap of $62.56 billion, a price-to-earnings ratio of 26.39 and a beta of 0.80. Colgate-Palmolive Company has a one year low of $63.43 and a one year high of $77.27. The firm’s 50-day moving average is $72.30 and its 200-day moving average is $72.91.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The business had revenue of $3.83 billion for the quarter, compared to the consensus estimate of $3.89 billion. During the same period in the prior year, the business posted $0.70 earnings per share. The company’s quarterly revenue was down .5% compared to the same quarter last year. Analysts expect that Colgate-Palmolive Company will post $2.89 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, August 15th. Shareholders of record on Tuesday, July 18th were given a dividend of $0.40 per share. The ex-dividend date was Friday, July 14th. This represents a $1.60 dividend on an annualized basis and a yield of 2.25%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 59.48%.
ILLEGAL ACTIVITY NOTICE: “Ameritas Investment Partners Inc. Buys 96 Shares of Colgate-Palmolive Company (CL)” was first posted by BNB Daily and is the sole property of of BNB Daily. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this article can be viewed at https://www.baseball-news-blog.com/2017/08/19/ameritas-investment-partners-inc-purchases-96-shares-of-colgate-palmolive-company-cl-updated-updated.html.
CL has been the subject of a number of analyst reports. Royal Bank Of Canada restated a “hold” rating and issued a $74.00 price objective on shares of Colgate-Palmolive in a research note on Monday, April 24th. Jefferies Group LLC reduced their price objective on shares of Colgate-Palmolive from $78.00 to $76.00 and set a “hold” rating for the company in a research note on Monday, May 1st. UBS AG reiterated a “neutral” rating and set a $78.00 target price (down from $79.00) on shares of Colgate-Palmolive in a research note on Tuesday, May 2nd. Zacks Investment Research cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Wednesday, May 3rd. Finally, Vetr cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 target price for the company. in a research note on Wednesday, May 17th. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $75.82.
In other news, SVP John J. Huston sold 14,000 shares of the stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $71.36, for a total value of $999,040.00. Following the sale, the senior vice president now directly owns 88,598 shares in the company, valued at $6,322,353.28. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, insider Patricia Verduin sold 3,833 shares of the stock in a transaction that occurred on Monday, July 17th. The stock was sold at an average price of $72.41, for a total value of $277,547.53. Following the completion of the sale, the insider now owns 53,022 shares in the company, valued at $3,839,323.02. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 221,802 shares of company stock worth $15,983,976. Company insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.